Market News & Analysis


Top Story

US Q4 GDP in Line but the Devil is in the Details

The markets appear to be taking the first look at the US GDP Growth Rate for Q4 in stride.   The headline number was in line with expectations of 2.1% vs a Q3 reading of 2.1%.  Net exports contributed to a large portion of this increase, which is a good thing.  However, personal consumption, which the Fed pays particularly close attention to, fell to 1.8% vs 2.0% expected and 3.2% in Q3.  In addition, Core Personal Consumption QoQ fell to 1.3% vs 1.6% expected and 2.1% in Q3.  For an economy which is often described by the phrase “Don’t underestimate the US consumer”, this is not good news.    

One of the Feds favorite tools for measuring inflation is the PCE Price Index.  The Advance PCE Price Index for Q4 increased 1.6% vs 1.7% expected, although this number did beat Q3 number of 1.5%.  However, more importantly is the Core PCE Price Index, which strips out the volatile prices of food and energy.  The Core PCE Price index only increased 1.3% vs 1.7% expected and 2.1% in Q3. 

Another measure of inflation from the GDP data is the GDP deflator, which measures changes in the prices of goods and services produced in the United States, including those exported to other countries.  Prices of imports are excluded.  (Bureau of Economic Analysis).  The GDP deflator for Q4 was 1.5% vs 1.8% expected and 1.7% in Q3.

Upon the release, the US Dollar Index and S&P 500 E-mini futures were little changed. However, both are currently lower.

DXY

Source: Tradingview, City Index

S&P 500

Source: Tradingview, CME, City Index

One would guess the Fed had this data yesterday.  But we need to ask the question:  with lower personal consumption and lower inflation data,  will that motivate the Fed to become more dovish if the data continues at this rate?


From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.